Department of Obstetrics and Gynaecology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
BMC Med. 2024 Nov 5;22(1):508. doi: 10.1186/s12916-024-03733-0.
Endometriosis is a chronic, estrogen-dependent, benign condition, affecting 10-15% of women of reproductive age. It is associated with a prevalence of sexual dysfunction that is nearly twice as high as that seen in women with other benign gynecological conditions. Our study aimed to assess the effect of surgical intervention on sexual function, as measured by the FSFI (Female Sexual Function Index) score, in women with endometriosis compared to those with other benign gynecological conditions, both before and after surgery.
A comparative analysis was conducted at the Medical University of Vienna from 2015 to 2020. The study included patients suspected of having endometriosis, fibroids, adnexal cysts, and/or infertility. Based on findings during surgery, patients were categorized into two groups: those with endometriosis (n = 64) and control patients (n = 38). All participants completed the FSFI questionnaire before surgery and again 8 to 18 weeks after the operation.
No significant differences were observed in the preoperative FSFI scores between the endometriosis patients and the control group. Similarly, no significant differences were found between the two groups in postoperative scores. However, in women diagnosed with endometriosis, surgical removal of endometriotic lesions significantly increased their full-scale FSFI score, and resulted in a significant improvement in the areas "desire" and "satisfaction". Improvements were noted in all other areas as well, though they were not statistically significant.
Our research indicates that the surgical removal of endometriotic lesions can lead to an improvement in sexual function, as measured by the FSFI, within 8 to 18 weeks post-surgery. This improvement was not observed in the control group, which underwent surgery for other benign gynecological issues.
子宫内膜异位症是一种慢性、雌激素依赖性、良性疾病,影响 10-15%的育龄妇女。它与性功能障碍的患病率有关,几乎是其他良性妇科疾病患者的两倍。我们的研究旨在评估手术干预对子宫内膜异位症患者(n=64)和对照组患者(n=38)的性功能的影响,采用 FSFI(女性性功能指数)评分进行评估,分别在手术前和手术后进行。
该研究于 2015 年至 2020 年在维也纳医科大学进行。研究纳入了疑似患有子宫内膜异位症、子宫肌瘤、附件囊肿和/或不孕的患者。根据手术中的发现,患者分为两组:子宫内膜异位症组(n=64)和对照组(n=38)。所有患者在手术前和手术后 8 至 18 周都完成了 FSFI 问卷。
子宫内膜异位症患者与对照组患者在术前 FSFI 评分方面没有显著差异。同样,两组患者在术后评分方面也没有显著差异。然而,在诊断为子宫内膜异位症的女性中,手术切除子宫内膜异位病灶显著提高了她们的 FSFI 总分,并导致“欲望”和“满意度”领域显著改善。其他所有领域也都有所改善,尽管没有统计学意义。
我们的研究表明,手术切除子宫内膜异位病灶可在术后 8 至 18 周内显著改善 FSFI 评分所衡量的性功能。在对照组中,这些患者因其他良性妇科问题而接受手术治疗,并未观察到这种改善。